ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1334

Contribution of Diagnostic Investigations in the Management of Uveitis: Retrospective Analysis of 300 Patients

Jérôme Hadjadj1, Thibault Chapron2, Manal Assala1, Sawsen Salah2, Bertrand Dunogue1, Matthieu Groh3, Philippe Blanche1, Luc Mouthon4, Dominique Monnet2, Claire Le Jeunne4, Antoine Brezin2 and Benjamin Terrier3, 1Internal Medicine, Cochin Hospital, Paris, France, 2Ophtalmology, Cochin Hospital, Paris, France, 3National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 4Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, Paris, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Diagnostic Tests, sarcoidosis and uveitis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Miscellaneous Rheumatic and Inflammatory Diseases - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Uveitis represents a diagnostic and therapeutic challenge, as well as an economic one, due to its heterogeneous presentation, multiple underlying causes and lack of well-codified diagnostic procedures. Furthermore, a third of uveitis is considered idiopathic. The aim of this study was to evaluate the contribution of diagnostic investigations in the management of uveitis in a specialized centre.

Methods: Single-centre retrospective study including patients referred from the Ophthalmology department to Internal Medicine practitioners for etiological diagnosis of uveitis. Uveitis related to pure ophthalmological diseases or occurring during the course of an already diagnosed pathology were excluded. All patients had a complete ophthalmologic examination followed by clinical and paraclinical exams. All diagnoses were established according to recent international diagnostic criteria.

Results: Three hundred consecutive patients were included (mean age 48 ± 30 years, men 49%). The main features of uveitis were: bilateral 56%, anterior 33%, posterior 8%, panuveitis 30%, granulomatous 44%, chronic 39%. Forty-three percent of patients had at least one clinical extra-ophthalmologic manifestation, such as arthralgia (17%) or general symptoms (15%). Regarding paraclinical exams, chest CT scan was performed in 94% of cases, and showed abnormal findings suggestive of pulmonary or mediastinal sarcoidosis in 39%. Factors associated with having an abnormal CT scan were blood lymphocytopenia (p=0.002) and increased angiotensin-converting enzyme (ACE) over 1.5 the upper limit of normal (ULN) (p=0.007). Salivary gland biopsy, performed in 76% of cases, led to the identification of granuloma in only 6%. Bronchoscopy was performed in 61% of cases, with bronchial biopsies showing granuloma in only 8% whereas bronchoalveolar lavage fluid (BALF) analysis revealed alveolar lymphocytosis suggestive of sarcoidosis (lymphocytes >15% and/or CD4/CD8 ratio >3.5) in 27%. Patients with granuloma on biopsies always had abnormalities on CT scan whereas 37% of patients with alveolar lymphocytosis had normal CT scan. Factors associated with having contributive BALF were vitreous snowballs (p=0.003), peripheral multifocal choroiditis (p=0.002), lymphocytopenia (p=0.03), and a >1.5 ULN ACE titer (p<0.0001). Cerebral MRI was performed in 56% of cases and was abnormal in 14%. Factors associated with abnormal MRI were retinal vasculitis (p=0.03) and a >1.5 ULN ACE titer. Lumbar puncture was performed in 44% but mainly showed non relevant abnormalities in 31%. Finally, at the end of the diagnostic workup, the main causes identified were uveitis associated with latent tuberculosis in 25%, sarcoidosis in 18% or Behçet’s disease in 5%. However, 37% of uveitis remained of undetermined origin. Baseline features from the latter did not differ from those in which a specific diagnosis was retained.

Conclusion: Despite an extensive clinical and paraclinical workup, an important proportion of uveitis remains of undetermined origin. Identification of factors associated with abnormal investigations might improve the optimal diagnostic workup adapted to each patient’s characteristics.


Disclosure: J. Hadjadj, None; T. Chapron, None; M. Assala, None; S. Salah, None; B. Dunogue, None; M. Groh, None; P. Blanche, None; L. Mouthon, None; D. Monnet, None; C. Le Jeunne, None; A. Brezin, None; B. Terrier, None.

To cite this abstract in AMA style:

Hadjadj J, Chapron T, Assala M, Salah S, Dunogue B, Groh M, Blanche P, Mouthon L, Monnet D, Le Jeunne C, Brezin A, Terrier B. Contribution of Diagnostic Investigations in the Management of Uveitis: Retrospective Analysis of 300 Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/contribution-of-diagnostic-investigations-in-the-management-of-uveitis-retrospective-analysis-of-300-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contribution-of-diagnostic-investigations-in-the-management-of-uveitis-retrospective-analysis-of-300-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology